ARCHIVES

New NIH Program To Develop Therapies For Rare, Neglected Diseases

This article is from The Cancer Letter archive.

Vol. 35 No. 24 | June 19, 2009

Download PDF Visit The Full Archive

Related Articles

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995

SBIR Solicitation Issued

September 13, 1996

Also in this 8-page issue: FISH assay predicts survival on Iressa, Univ. of Colorado Cancer Center study finds.

May 6, 2005

CHOP Evaluation Plan In Jan. 22 Issue

January 15, 1982

NTP Board Plans Peer Review Of Bioassay Reports

April 11, 1980

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000